skip to main content

ProfessionalsMatthew D. Stachel

Matthew D. Stachel
Partner

Tel: +1-302-655-4423
Fax: +1-302-397-2682
mstachel@paulweiss.com

+1-302-655-4423
Wilmington

1313 North Market Street, Suite 806 Post Office Box 32
Wilmington, DE 19899-0032
Fax: +1-302-397-2682

+ vCard ADD TO CONTACTS
Education 
Bar Admissions 
Education 
Bar Admissions 

A partner in the Litigation Department, Matt Stachel specializes in Delaware corporate and commercial litigation. He has extensive experience litigating in the Delaware Court of Chancery as well as in Delaware federal and state courts, both at the trial and appellate levels. Matt’s practice encompasses a range of litigation matters, including actions involving the fiduciary duties of directors, officers and controlling stockholders; mergers and acquisitions litigation; stockholder derivative litigation and securities fraud litigation; stockholder demands and Section 220 actions; and other corporate governance disputes. He also regularly advises major public companies, boards of directors and special board committees, and private equity investors and their portfolio companies on their rights and obligations under Delaware law.

EXPERIENCE

Matt has achieved numerous exceptional results on behalf of his clients in state and federal courts across the country. Among others, his recent achievements include representing:

  • International Construction Products (ICP), a now-defunct heavy construction equipment importer, in securing a $100 million jury verdict in the District of Delaware in its nearly decade-long lawsuit against industry giant Caterpillar.
  • The Kraft Heinz Company and certain current or former Kraft Heinz officers and directors in winning the dismissal, with prejudice, of a stockholder derivative lawsuit in the Delaware Court of Chancery seeking to reopen claims related to a $1.2 billion stock sale by 3G Capital affiliates, which had been previously dismissed in 2021 and affirmed by the Delaware Supreme Court in 2022; and in winning the dismissal, with prejudice, of a stockholder derivative lawsuit in the Delaware Court of Chancery over alleged misleading statements about the company’s performance and cost-cutting efforts.
  • Exxon Mobil Corporation and certain of its former executives in substantially defeating the plaintiff’s class certification motion in a long-running putative federal securities class action in the Northern District of Texas alleging that the company made a series of false and misleading statements that artificially inflated the company’s stock price, costing stockholders billions of dollars.

Matt’s additional experience in stockholder derivative and securities fraud litigation includes representing:

  • Alexion Pharmaceuticals, the country’s then-largest orphan drug company, in a federal derivative action alleging misrepresentations and omissions about Soliris—a drug used to treat certain rare blood disorders.
  • Nikola Corporation, a manufacturer of heavy-duty commercial battery-electric vehicles, and several of its officers and directors, in derivative litigation in Arizona and Delaware, regarding alleged misstatements about the company’s products and performances.
  • Snap, Inc., and several of its directors and executives, in stockholder derivative actions concerning Snap’s preparation for Apple’s rollout of new privacy changes.
  • Teladoc Health, in the dismissal of derivative claims filed by stockholders alleging that the company misstated its policies governing workplace conduct following a #MeToo scandal, which led to the resignation of a senior executive.
  • World Wrestling Entertainment, Inc. ("WWE") in connection with stockholder derivative litigation alleging that WWE made misleading statements regarding the status of WWE’s media rights agreements in the Middle East and North Africa region.
  • NextEra Energy, the parent of Florida Power & Light, in derivative litigation concerning political contributions.

Matt’s additional experience in mergers & acquisitions litigation and other transaction-related disputes includes representing:

  • the Special Committee of the Board of Directors of Pattern Energy Group Inc., a California-based independent power company, in litigation challenging Pattern Energy’s $6.1 billion go-private sale to the Canada Pension Plan Investment Board.
  • certain former directors and officers of Bioverativ Inc., a biopharmaceutical company focused on rare blood disorders, in a stockholder class action in the Delaware Court of Chancery alleging that the directors and officers violated their fiduciary duties in connection with Bioverativ’s $11.6 billion sale to Sanofi.
  • Advance, a privately-owned investment company, and several current and former officers and directors in a stockholder class action brought in the Delaware Court of Chancery asserting breach of fiduciary duty claims related to the $43 billion merger between AT&T’s WarnerMedia and Discovery Inc., which Advance founded and is a majority shareholder of.
  • certain independent directors of Empire Resorts in stockholder litigation asserting breach of fiduciary duty claims relating to a take-private acquisition of Empire.
  • Virtu Financial in a stockholder Section 220 books and records action seeking information concerning certain distributions made by Virtu to certain stockholders.

© 2025 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy